by Ken Chiacchia | Sep 2, 2020 | Science Highlights
Anton 2 Simulations Kick off Drug Safety Prediction Pipeline Many possibly useful drugs are abandoned because they increase the QT interval of the heartbeat. This is because QT prolongation can cause life-threatening side effects. But not all QT-prolonging drugs are...
by Ken Chiacchia | Sep 2, 2020 | Science Highlights
Combination of Bridges and Anton 2 Allows Team to Span Time Scales in Simulating Dagger-Like Microbe-Killing Molecule Medical science is in a race to develop new and better antimicrobial agents to address infection and other human diseases. One promising example of...
by Ken Chiacchia | Sep 2, 2020 | Science Highlights
Introducing Experimental Data into Molecular Simulations on Bridges Improves Predictions of Metallic Glass Structure Metallic glass has great strength and flexibility and can be engineered for specific uses. These properties make it useful for medical devices,...
by Ken Chiacchia | Sep 2, 2020 | Science Highlights
Bridges Refines Protein Simulations, Approaching Lab Accuracy To understand how the tiny machinery of life works in health and disease, scientists need accurate pictures of how proteins fold and move. But laboratory methods for imaging proteins are slow, and so the...
by Ken Chiacchia | Aug 28, 2020 | Collaborations, Press release
Sept. 1, 2020 HuBMAP (the Human BioMolecular Atlas Program) has released its inaugural data for use by the scientific community and the general public. Included in this release are detailed, 3D anatomical data and genetic sequences of healthy tissues from seven...